Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2011
01/04/2011CA2515725C Novel crystalline modification of the anhydrate of boscalid
01/04/2011CA2488363C O-substituted hydroxyaryl derivatives
01/04/2011CA2451241C Unsymmetrical cyclic diamine compound
01/04/2011CA2435908C Aromatic derivatives as hiv aspartyl protease inhibitors
01/04/2011CA2421228C Polyarylcarboxamides useful as lipid lowering agents
01/04/2011CA2397798C Substituted pyridine compounds useful for controlling chemical synaptic transmission
01/04/2011CA2360451C N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
01/04/2011CA2319672C Compounds and compositions for delivering active agents
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
01/04/2011CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them
12/2010
12/30/2010US20100331549 Novel compounds useful for modulating abnormal cell proliferation
12/30/2010US20100331540 Method for producing compound having deuterated aromatic ring or heterocyclic ring
12/30/2010US20100331376 Process for Recovering Flunixin From Pharmaceutical Compositions
12/30/2010US20100331366 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331321 Bis-(Sulfonylamino) derivatives for use in therapy
12/30/2010US20100331303 Prolyl hydroxylase inhibitors and methods of use
12/30/2010US20100330032 Heterocyclic antiviral compounds
12/30/2010US20100328600 Liquid crystal compound, liquid crystal composition and liquid crystal display device
12/30/2010US20100327270 Novel materials for organic electroluminescent devices
12/30/2010US20100327265 Bipiridine derivative and organic electroluminescence element containing the same
12/30/2010US20100327226 Liquid-crystalline medium and liquid-crystal display
12/29/2010WO2010151389A1 Process for making organic compounds and the organic compounds made therefrom
12/29/2010WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010WO2010150192A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/29/2010WO2010149956A1 4 -aminopicolinates and their use as herbicides
12/29/2010WO2010149888A1 Derivatives of 2-mercaptocyclopentane carboxylic acid, method for the preparation thereof, and pharmaceutical compositions containing the same
12/29/2010WO2010149356A1 Process for the preparation of arylpyridinyl compounds
12/29/2010WO2010149352A2 Synthesis process for 3-methylpyridine
12/29/2010WO2010132670A3 Pentacycline compounds
12/29/2010WO2010122426A3 Methods and compositions for visualization of fluorescent proteins
12/29/2010EP2266971A2 Hiv protease inhibiting compounds
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265585A1 Amine and ether compounds which modulate the cb2 receptor
12/29/2010EP2265575A2 Sulfonamides
12/29/2010EP2265574A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010CN1907972B Process for preparing 2,3,5,6-tetraaminopyridine
12/29/2010CN101932562A Carbamoyl compounds as dgat1 inhibitors 190
12/29/2010CN101932561A Crystalline form of an antimalarial compound
12/29/2010CN101932319A Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
12/29/2010CN101928274A Peperphentonamine derivative
12/29/2010CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them
12/29/2010CN101565399B Method for synthesizing 2-chloro-3-amino-4-methylpyridine by ethyl cyanoacetate and acetone
12/29/2010CN101367760B Synthesis of 2-chlorine apellagrin
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2766665A1 Process for the preparation of arylpyridinyl compounds
12/29/2010CA2766104A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/29/2010CA2765462A1 Mexiletine amino acid and peptide prodrugs and uses thereof
12/29/2010CA2764956A1 Novel biphenyl and phenyl-pyridine amides
12/29/2010CA2764200A1 4 -aminopicolinates and their use as herbicides
12/29/2010CA2763574A1 Process for the synthesis of 3-methyl-pyridine
12/28/2010US7858648 Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA
12/28/2010US7858646 1-(2-hydroxy-3-methyl-4-{4-[4-(1H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-phenyl)-ethanone; 6-(3-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)phenylthio)isonicotinic acid; 1-(2-hydroxy-4-{3-[4-(2H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-3-trifluoromethyl-phenyl)-ethanone; treatment of migriane
12/28/2010US7858643 Crizotinib, a c-Met protein kinase inhibitor anticancer agent; 3-[(R)-1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine is crizotinib
12/28/2010US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/28/2010US7858624 such as methyl 2-((R)-((R)-1-((2S,3S)-5-(butylamino)-1-cyclohexyl-3-hydroxy-5-oxopentan-2-ylcarbamoyl)piperidin-3-yl)(3-chlorophenyl)methoxy)ethylcarbamate, used as hypotensive agents or for the treatment of cardiovascular disorders, vision defects, aldosteronism and obesity
12/28/2010US7858621 Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010147017A1 Display element and color electronic paper using same
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146119A1 Preparation process of an antivirally heterocyclic azahexane derivative
12/23/2010WO2010146083A1 Anthelmintic agents and their use
12/23/2010WO2010145790A1 Propargyloxybenzamide derivatives
12/23/2010WO2010145764A1 Substituted enamino carbonyl compounds
12/23/2010WO2010145197A1 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010097802A3 A process for the preparation of etoricoxib
12/23/2010WO2010091876A3 Small molecule bradykinin b1 receptor antagonists
12/23/2010WO2009146555A8 Hiv integrase inhibitors from pyridoxine
12/23/2010US20100324299 Method for purification of pyridine, and method for production of chlorinated pyridine
12/23/2010US20100324140 Glucagon receptor antagonists, preparation and therapeutic uses
12/23/2010US20100324103 Substituted Enaminocarbonyl Compounds
12/23/2010US20100324102 N-(3-pyridin-2-ylpropyl) benzamide derivatives as fungicides
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324092 Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
12/23/2010US20100324086 Compounds and methods
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324064 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
12/23/2010US20100324061 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
12/23/2010US20100324058 thrombin function compounds and pharmaceutical compositions based on them
12/23/2010US20100324052 Novel piperidine carboxylic acid amine derivatives
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010CA2765130A1 Anthelmintic agents and their use
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264012A1 Heteroarylamidines and their use as fungicides
12/22/2010EP2264011A1 Heteroarylamidines and their use as fungicides
12/22/2010EP2264010A1 Hetarylamidines
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2264008A1 Substituted enaminocarbonyl compounds
12/22/2010EP2262805A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262804A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262803A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262771A1 A method for the preparation of dabigatran
12/22/2010EP2262770A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 633